Projects per year
Personal profile
Research interests
Biological Sciences - Cell cycle control
Biotechnology - Cancer
Biotechnology - Biotechnology
Related documents
Education/Academic qualification
PhD in Biology, PhD, Brown University
1993
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
-
SDG 6 Clean Water and Sanitation
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Development of an inhaled liposomal drug based on the new anticancer targets DNA replication-initiation proteins
LIANG, C. (PI), LIU, X. (CoI), SU, H. (CoI), YANG, L. (CoI) & ZHANG, Z. (CoI)
Department of Science and Technology of Guangdong Province
12/09/22 → 11/09/27
Project: Research
-
The Roles, Mechanisms and Regulation of NOC3 Dimerization and ORC Dimerization in Yeast and Human Cells
LIANG, C. (PI)
1/07/21 → 30/06/24
Project: Research
-
Antisense Oligonucleotides Targeted to Human CDC45: [United States]
LIANG, C. (Key Inventor) & YU, Z. (Inventor), 19 Aug 2004, IPC No. C07H 21/04, A61K 31/70, A61K 38/00, C12N 15/113, Patent No. 7393950, 29 Aug 2002, Priority date 29 Aug 2002Research output: Patent
-
Identifying genetic susceptibility loci associated with human coronary artery disease
Zahid, A., Batool, A., Wajid, A., Wu, Y., Liang, C., KHAN, M. A., Ullah, A., Sahibzada, K. I. & XUE, H., 9 Jan 2025, In: PLoS ONE. 20, 1, e0315460.Research output: Contribution to journal › Journal Article › peer-review
Open Access1 Link opens in a new tab Citation (Scopus) -
Non-clinical and clinical research on innovative DNA replication-initiation proteins (DRIPs) inhibitors derived from natural products as anticancer drugs
LIANG, C., Apr 2025.Research output: Contribution to conference › Conference Paper › peer-review
-
Preclinical and Clinical Studies of First-in-class DRIP Inhibitors as Highly Efficacious Anticancer Drug Candidates
LIANG, C., Mar 2025.Research output: Contribution to conference › Conference Paper › peer-review
-
Research and Development of First-in-class DRIP Inhibitor Anticancer Drugs
LIANG, C., May 2025.Research output: Contribution to conference › Conference Paper › peer-review
Activities
- 4 Editorial work
-
Frontiers Cell Dev. Biol. (Journal)
LIANG, C. (Associate Editor)
1 Jan 2016 → …Activity: Publication peer-review and editorial work › Editorial work
-
J. Biomed. Tech. Res. (Journal)
LIANG, C. (Chief Editor)
1 Dec 2013 → …Activity: Publication peer-review and editorial work › Editorial work
-
Chinese Journal of Biology (Journal)
LIANG, C. (Editorial Board Member)
1 May 2013 → …Activity: Publication peer-review and editorial work › Editorial work
-
BMC Molecular Biology (Journal)
LIANG, C. (Associate Editor)
1 Sept 2008 → …Activity: Publication peer-review and editorial work › Editorial work
Awards
-
Gold Metal, the 50th Geneva international exhibition of inventions
LIANG, C. (Recipient), Apr 2025
Prize: Honorary Award
-
-
-
Excellent Award (the highest) of Disruptive Innovation Technology
LIANG, C. (Recipient), Apr 2023
Prize: Honorary Award
-
National Foreign Experts Program of the Ministry of Science and Technology of China
LIANG, C. (Recipient), Aug 2023
Prize: Research Fellowship